These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Facilitation by oxygen of an induced hyperpyrexia during general anesthesia in dogs. Morgan JG; Gatz EE J Oral Surg; 1974 Nov; 32(11):823-8. PubMed ID: 4530072 [No Abstract] [Full Text] [Related]
24. Biochemical studies on malignant hyperpyrexia. Pennington RJ; Worsfold M Proc R Soc Med; 1973 Jan; 66(1 Pt 1):69-70. PubMed ID: 4266079 [No Abstract] [Full Text] [Related]
25. [Study of the efficiency of sampling on activated charcoal of difluoromethyl-2-chloro-1,1,2-trifluoro-ethyl ether and 1,1,1, trifluoro-2-chloro-2-bromo-ethane and its use in some operating rooms]. Valente T; Pane L; Chiapperini D Ann Ist Super Sanita; 1978; 14(3):497-502. PubMed ID: 755401 [No Abstract] [Full Text] [Related]
26. [Anesthesiologic management of susceptible children at risk for malignant hyperthermia]. Ferrari F; D'Alessandro S; Pietrandrea G; Villani A Minerva Anestesiol; 1997 Oct; 63(10):311-4. PubMed ID: 9567608 [TBL] [Abstract][Full Text] [Related]
27. Halothane and nitrous oxide in end-tidal air and venous blood of surgical personnel. Pfäffli P; Nikki P; Ahlman K Ann Clin Res; 1972 Oct; 4(5):273-7. PubMed ID: 4644450 [No Abstract] [Full Text] [Related]
28. [2 cases of malignant hyperpyrexia--with special reference to successful treatment by femoral VA bypass]. Iuchi Y; Madono K; Yamamoto T; Yoshizumi M; Ono T Masui; 1972 May; 21(5):487-93. PubMed ID: 4672628 [No Abstract] [Full Text] [Related]
29. Malignant hyperthermia in the otolaryngologic patient: prospective anesthetic and surgical management of eight children. Dudley JP; Reynolds R; Dubrow TJ Ann Otol Rhinol Laryngol; 1990 Apr; 99(4 Pt 1):297-9. PubMed ID: 2327699 [TBL] [Abstract][Full Text] [Related]
30. [Concentration of halothane in the air of operating rooms]. Vedel AJ; Brendstrup A Nord Med; 1970 Dec; 84(51):1635. PubMed ID: 5490751 [No Abstract] [Full Text] [Related]
31. Pathology of malignant hyperpyrexia. Br Med J; 1973 Feb; 1(5848):249. PubMed ID: 4685313 [No Abstract] [Full Text] [Related]
32. Factitious halothane detection during trigger-free anesthesia in a malignant hyperthermia susceptible patient. Hawkes CA Can J Anaesth; 1999 Jun; 46(6):567-70. PubMed ID: 10391605 [TBL] [Abstract][Full Text] [Related]
33. [Malignant hyperthermia following halothane anesthesia for more than 3 hours]. Schiffner H; Heckemann R; Schnabel P Anaesthesiol Reanim; 1986; 11(4):215-20. PubMed ID: 3019364 [No Abstract] [Full Text] [Related]
34. A laboratory animal model for malignant hyperpyrexia. Durbin CG; Rosenberg H J Pharmacol Exp Ther; 1979 Jul; 210(1):70-4. PubMed ID: 36478 [TBL] [Abstract][Full Text] [Related]
35. General anesthesia in a malignant hyperthermia susceptible patient. Jones JE; Dierdorf SF; Clapp DW J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215 [No Abstract] [Full Text] [Related]
36. [Prevention of the clinical forms of malignant hyperthermia and safe anesthesia]. Brancadoro V; Tufano R Minerva Anestesiol; 1992 Oct; 58(10):1009-11. PubMed ID: 1461390 [No Abstract] [Full Text] [Related]
38. Awake malignant hyperthermia: report of a case to help prevent crises in operating rooms. Puerto N; Aoyama K; Der T; Luginbuehl I; Karsli C; Zeller R; Zaarour C Can J Anaesth; 2023 Jan; 70(1):169-171. PubMed ID: 36369638 [No Abstract] [Full Text] [Related]
39. Gas scavenging during bronchoscopy under general anesthesia. Ostfeld E; Blonder J; Szeinberg A; Dagan J Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):146-9. PubMed ID: 6424537 [TBL] [Abstract][Full Text] [Related]
40. Concentrations of anaesthetic gases in hospital operating theatres. Sitarek K; Wesołowski W; Kucharska M; Celichowski G Int J Occup Med Environ Health; 2000; 13(1):61-6. PubMed ID: 10846846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]